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Abstract
Background: The guanine nucleotide exchange factor C3G (RapGEF1) along with its effector
proteins participates in signaling pathways that regulate eukaryotic cell proliferation, adhesion,
apoptosis and embryonic development. It activates Rap1, Rap2 and R-Ras members of the Ras
family of GTPases. C3G is activated upon phosphorylation at tyrosine 504 and therefore,
determining the localization of phosphorylated C3G would provide an insight into its site of action
in the cellular context.
Results:  C3G is phosphorylated in vivo on Y504 upon coexpression with Src or Hck, two
members of the Src family tyrosine kinases. Here we have determined the subcellular localization
of this protein using antibodies specific to C3G and Tyr 504 phosphorylated C3G (pY504 C3G).
While exogenously expressed C3G was present mostly in the cytosol, pY504 C3G formed upon
Hck or Src coexpression localized predominantly at the cell membrane and the Golgi complex.
Tyrosine 504-phosphorylated C3G showed colocalization with Hck and Src. Treatment of Hck and
C3G transfected cells with pervanadate showed an increase in the cytosolic staining of pY504 C3G
suggesting that tyrosine phosphatases may be involved in dephosphorylating cytosolic phospho-
C3G. Expression of Src family kinases or treatment of cells with pervanadate resulted in an increase
in endogenous pY504 C3G, which was localized predominantly at the Golgi and the cell periphery.
Endogenous pY504 C3G at the cell periphery colocalized with F-actin suggesting its presence at the
subcortical actin cytoskeleton. Disruption of actin cytoskeleton by cytochalasin D abolished
phospho-C3G staining at the periphery of the cell without affecting its Golgi localization.
Conclusions: These findings show that tyrosine kinases involved in phosphorylation of C3G are
responsible for regulation of its localization in a cellular context. We have demonstrated the
localization of endogenous C3G modified by tyrosine phosphorylation to defined subcellular
domains where it may be responsible for restricted activation of signaling pathways.
Background
Guanine nucleotide exchange factors (GNEFs) are compo-
nents of signaling pathways that link transmembrane
receptors to intracellular GTPase family members regulat-
ing a wide variety of cellular functions such as prolifera-
tion, differentiation, adhesion and apoptosis. C3G
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(RapGEF1) is an ubiquitously expressed GNEF for Ras
family proteins that particularly targets Rap1, Rap2 and R-
Ras [1-4]. It has been shown to mediate signals received
from B and T cell receptor activation, growth factors,
cytokines, G protein coupled receptors and also adhesion
[5-15]. C3G is present in the cytoplasm in a complex with
members of the Crk family of small adapter molecules. In
response to stimuli, this complex is recruited to the cell
membrane involving association of Crk with phosphoty-
rosine containing proteins like receptor tyrosine kinases,
p130 Cas, IRS-1 and paxillin [16-18]. Following transloca-
tion from cytosol to cell membrane, C3G activates down-
stream signaling. Its activation has been shown to lead to
an activation of mitogen activated protein kinase and Jun
N-terminal kinase [9,12,19-21]. Studies involving overex-
pression of membrane targeted C3G or dominant nega-
tive forms have shown that C3G is involved in both
growth suppression as well as transformation [22-24].
C3G appears to play an important role in mammalian
development because C3G-/- mice die before embryonic
day 7.5. These studies have shown that C3G is required for
vascular myogenesis and for cell adhesion and spreading
[25,26].
The C-terminus of C3G, which shows homology to
CDC25, harbors the catalytic domain. The central region
of C3G, which spans about 300 residues, has polyproline
tracts with the ability to bind to SH3 domains of various
proteins like Crk, p130 Cas, Grb2 and Hck [1,2,9,18,27].
No function has particularly been attributed to the N-ter-
minal sequences, which do not show homology to any
defined protein sequences. The non-catalytic domain of
C3G has been shown to negatively regulate its catalytic
activity. Deletion of the N-terminal sequences or its asso-
ciation through its proline sequences to Crk leads to its
activation [16]. Integrin mediated cell adhesion causes
tyrosine phosphorylation of C3G [28]. It has been shown
that overexpression of c-Crk1 or stimulation of cells with
growth hormone leads to specific phosphorylation of
Y504 [21,29]. This modification results in an increase in
C3G catalytic activity towards Rap1. Src and JAK have
been implicated in Y504 phosphorylation of C3G. More
recently we have used site – specific antibodies to show
that the activation of Src family kinase Hck, leads to C3G
phosphorylation on Y504 suggesting that Src family
kinases can directly regulate C3G activity and function
[27].
The effectiveness and precision of intracellular signal
transduction depends on protein-protein interactions that
regulate enzyme activity as well as subcellular localiza-
tion. Cell surface receptor activation leads to assembly of
adaptor protein complexes at the plasma membrane,
which serve to localize guanine nucleotide exchange pro-
teins. Earlier, both endogenous as well as exogenously
expressed C3G has been shown to localize to the cyto-
plasm and not to associate with plasma membrane
[22,30]. Since activation of C3G occurs primarily through
phosphorylation at Tyr 504 and membrane recruitment,
we undertook a detailed study of the subcellular localiza-
tion of both exogenously expressed and endogenous Y504
phosphorylated C3G (pY504 C3G). Expression of Src
family kinases or pervanadate treatment of cells, which
mimics stimulation by growth factors, resulted in marked
tyrosine phosphorylation of C3G at Y504. Conventional
as well as optical sectioning microscopy revealed that
pY504 C3G was predominantly located at the Golgi com-
plex and the subcortical actin cytoskeleton unlike non-
phosphorylated C3G, which was largely cytosolic.
Results
Colocalization of C3G with Hck
We have recently shown that Hck interacts with and phos-
phorylates C3G in vivo and we wished to determine if
their interaction leads to changes in the subcellular distri-
bution of C3G and whether pY504 C3G locates to specific
subcellular domains. Cos-1 cells were transfected with
C3G in the presence or absence of Hck and immunos-
tained using anti C3G antibodies. As shown in Fig. 1A in
a majority of cells, exogenously expressed C3G showed
diffuse cytoplasmic staining that extended up to the
plasma membrane. Variation in the level of C3G was
observed among the transfected cells with weakly express-
ing cells showing a more prominent juxtanuclear staining.
When cotransfected with Hck, most cells showed promi-
nent staining of C3G at the plasma membrane and a jux-
tanuclear organelle in addition to the diffuse cytoplasmic
staining. This pattern appeared similar to that seen for
exogenously expressed Hck and therefore we performed
colocalization studies to confirm their distribution. When
coexpressed, Hck and C3G are targeted predominantly to
the plasma membrane and other intracellular membra-
nous structures (Fig. 1B). Merged images show that these
two proteins colocalize in the subcellular context. Similar
patterns of colocalization were observed when C3G and
Hck were expressed in HeLa cells (data not shown).
Src family kinases phosphorylate C3G and phospho-C3G 
localizes to the Golgi and plasma membrane
To determine the subcellular distribution of phospho-
C3G, which is known to be the activated form, specificity
of a rabbit polyclonal phosphorylation site-specific anti-
body (pY504-C3G) was verified by examining its reactiv-
ity using cell lysates expressing C3G or Y504F-C3G alone
or with Hck. As shown in Fig. 2A, pY504-C3G antibody
recognizes only C3G when coexpressed with Hck. Neither
the C3G protein expressed in itself nor the Y504F mutant
coexpressed with Hck show any reactivity with this anti-
body suggesting that it reacts only with Y504 phosphor-
ylated C3G. Phosphotyrosine blotting showed that a largeBMC Cell Biology 2004, 5:31 http://www.biomedcentral.com/1471-2121/5/31
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number of cellular polypeptides are phosphorylated on
tyrosine upon Hck expression, (Fig. 2A, right panel) but
except for C3G none of the others show any reactivity with
pY504 antibody. Y504F mutant of C3G, which shows low
Subcellular localization of C3G Figure 1
Subcellular localization of C3G. (A) Cos-1 cells grown on coverslip were either transfected with C3G or cotransfected 
with Hck and indirect immunofluorescence staining performed using anti-C3G antibodies and Cy3 conjugated anti rabbit sec-
ondaries. (B) Cells transfected with Hck and C3G were stained for both the antigens as described in Materials and Methods. 
Hck was visualized using FITC conjugated secondaries and C3G by Cy3 conjugated secondaries. The dual panel shows the 
merged image of an optical section taken using the confocal microscope where the yellow signal generated shows colocaliza-
tion of the two proteins.
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Specificity of phosphospecific antibody, and phosphorylation of C3G on Y504 upon coexpression with Src family kinases Figure 2
Specificity of phosphospecific antibody, and phosphorylation of C3G on Y504 upon coexpression with Src fam-
ily kinases. Cos-1 cells were transfected with the expression constructs for Hck (A) or c-Src (B) along with C3G as indicated 
and western blotting of whole cell lysates was performed using the phosphospecific antibody pY504. The blots were reprobed 
with C3G, Hck and anti pTyr (Panel A) or Src (Panel B) to show their expression in the lysates. pY504 C3G and pTyr was 
detected by ECL and C3G, Hck and Src by alkaline phosphatase dependent color development. UT indicates untransfected cell 
lysates. Y504F is a mutant of C3G in which tyrosine 504 is replaced by phenylalanine.
C3G
pY504
Src
S
r
c
+
C
3
G
S
r
c
+
Y
5
0
4
F
H
c
k
+
C
3
G B
U
T
H
c
k
C
3
G
H
c
k
+
C
3
G
Y
5
0
4
F
H
c
k
+
Y
5
0
4
F
pY504
C3G
Hck
A
93
67
45
30
pTyr
U
T
H
c
k
C
3
G
H
c
k
+
C
3
G
Y
5
0
4
F
H
c
k
+
Y
5
0
4
FBMC Cell Biology 2004, 5:31 http://www.biomedcentral.com/1471-2121/5/31
Page 5 of 15
(page number not for citation purposes)
level of phosphorylation on other tyrosine residues is not
detected by this antibody indicating its specificity towards
Y504 phosphorylated C3G. Unlike Hck, whose expression
is restricted to a subclass of hematopoietic cells, C3G is
ubiquitously expressed and we wished to determine if
other Src family kinases could phosphorylate C3G. We
coexpressed C3G with an expression construct for the
fusion protein c-Src-GFP and western blotting was per-
formed using pY504-C3G antibody. As shown in Fig. 2B,
in vivo, c-Src was also able to induce Y504 phosphoryla-
tion of C3G, but not that of the Y504F C3G mutant.
We wished to determine whether C3G that colocalizes
with Hck was the phosphorylated component and there-
fore used pY504-C3G antibodies to determine the locali-
zation of pY504 C3G in cells expressing Hck and C3G. As
shown in Fig. 3A, pY504 C3G showed a staining pattern
that exactly matched that of Hck with prominent staining
of the plasma membrane, a juxtanuclear organelle and
other intracellular membranes (3A). The prominent stain-
ing appeared to correspond with the Golgi structure and
Hck has earlier been shown to localize to the Golgi [31].
In cells transfected with C3G and Hck, the pattern of
pY504 C3G staining was also compared with that of total
C3G as detected by the Flag tag antibody. As shown in Fig.
3B, it was observed by confocal analysis that the tag anti-
body detects the presence of C3G spread throughout the
cytoplasm with some prominence in the juxtanuclear
region and plasma membrane. The pattern suggests that
the majority of the protein is cytosolic. In contrast staining
for phospho-C3G was non-uniform and was particularly
prominent at the Golgi and cell membrane. Colocaliza-
tion of C3G with that of phospho-C3G is seen at the
plasma membrane and in the juxtanuclear region. This
also suggests that only a proportion of the expressed C3G
is phosphorylated at Tyr504. To confirm the presence of
pY504 C3G in the Golgi, we coexpressed the viral protein,
VSVG-GFP known to localize to the Golgi with Hck and
C3G and observed the staining pattern of pY504 C3G and
that of GFP. VSVG-GFP locates predominantly at the
Golgi, trans-Golgi network and also the endoplasmic
reticulum and plasma membrane in a temperature-
dependent manner [32]. As shown in Fig. 3C, the yellow
signal generated in the dual image showed colocalization
of pY504 C3G with VSVG-GFP suggesting that pY504 C3G
was predominantly targeted to the Golgi complex. Unlike
C3G, pY504 C3G appeared to be restricted to the plasma
membrane and other intracellular membranes with par-
ticular concentration in the Golgi. When overexpressed, a
large amount of C3G was present in the cytosol and we
wished to determine whether cytosolic C3G does not get
phosphorylated upon Hck coexpression or whether
pY504 C3G in the cytosol is transient due to the action of
tyrosine phosphatases. Cos-1 and HeLa cells transfected
with Hck and C3G were either left untreated, or, subjected
to pervanadate treatment for 10 minutes prior to fixation
and stained for pY504 C3G. Pervanadate is a strong inhib-
itor of tyrosine phosphatases; therefore treatment of cells
with pervanadate results in dramatic augmentation of
tyrosine phosphorylation on cellular proteins [33]. As
shown in Fig. 3D, pervanadate-treated cells showed an
increase in the pY504 C3G staining in the cytoplasm sug-
gesting that it was dephosphorylated by cytosolic tyrosine
phosphatases.
Phosphorylation of endogenous C3G and its localization 
to the Golgi and subcortical actin cytoskeleton
In the above experiments phosphorylation and localiza-
tion of C3G was studied using exogenously expressed pro-
tein and we wished to determine whether endogenous
C3G could be phosphorylated and similarly targeted.
Towards this end we checked the phosphorylation of
endogenous C3G under conditions of Src and Hck overex-
pression or upon activation of cellular tyrosine kinases by
pervanadate treatment. C3G protein is expressed as a dou-
blet of about 140–150 kDa, which are products of two dif-
ferentially spliced mRNAs [34]. Whole cell lysates were
prepared from Cos-1 cells and those transfected with Hck
or Src and western blotting performed using pY504 anti-
bodies. As shown in Fig. 4A, overexpression of Src or Hck
induces tyrosine 504 phosphorylation of endogenous
C3G. The same blot was reprobed with C3G, Src and Hck
antibodies to show their presence in the lysates. We exam-
ined the localization of endogenous phosphorylated C3G
after c-Src expression and found that similar to the phos-
phorylated form of the exogenously expressed C3G,
endogenous pY504 C3G was present predominantly at
sites of c-Src localization. Intense staining of the Golgi and
cell membranes was evident and merged images show
colocalization of the two proteins (4B). Cells that did not
express Src, did not show any phosphorylated C3G.
The localization of endogenous pY504 C3G to the Golgi
was examined in Cos-1 cells transfected with Hck and
VSVG-GFP. Immunostaining for pY504 C3G was seen
predominantly at the cell periphery and the Golgi (Fig.
4C), which was confirmed by colocalization with VSVG-
GFP. The effect of Golgi perturbing drugs on the localiza-
tion of pY504 C3G was examined by treatment of cells
with nocadazole for depolymerization of microtubules
and concomitant Golgi fragmentation. Under these con-
ditions pY504 C3G was detected as dispersed vesicles scat-
tered in the cytoplasm and remained colocalized with
VSVG-GFP (4C) confirming that endogenous pY504 C3G
localized to the Golgi complex.
The localization of pY504 C3G formed by the activation
of endogenous tyrosine kinases was determined in cells
treated with pervanadate, which is known to activate Src
family kinases, in addition to inhibiting tyrosineBMC Cell Biology 2004, 5:31 http://www.biomedcentral.com/1471-2121/5/31
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pY504-C3G colocalizes with Hck and shows predominant Golgi and membrane localization Figure 3
pY504-C3G colocalizes with Hck and shows predominant Golgi and membrane localization. (A) pY504 C3G 
colocalizes with Hck. Cos-1 cells transfected with Hck and C3G were stained for pY504 C3G (Cy3) and Hck (FITC) and exam-
ined using a confocal microscope. Figure shows an optical section for the individual stains as well as that of the merged (Dual) 
image. (B) Cos-1 cells transfected with Hck and C3G were dual labeled to detect phospho-C3G (Cy3 staining) and C3G using 
the Flag tag antibody (FITC staining). Panels show optical sections taken using the confocal microscope. (C) pY504 C3G is 
localized to the Golgi apparatus. Cos-1 cells were transfected with Hck, C3G and VSVG-GFP expression constructs and 
stained using pY504 primary antibody and Cy3 conjugated secondary. An optical section taken using the apotome is repre-
sented. (D) HeLa or Cos-1 cells transfected with Hck and C3G were left untreated (control) or treated with pervanadate (PV) 
prior to fixation and stained for pY504. Counter staining with Dapi shows cell nuclei.
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Phosphorylation of endogenous C3G upon overexpression of Hck and its localization to the Golgi Figure 4
Phosphorylation of endogenous C3G upon overexpression of Hck and its localization to the Golgi. (A) Cos-1 
cells were transfected with expression constructs as indicated and whole cell lysates used in western blotting for pY504-C3G. 
ECL was used for detection. Blots were reprobed to show expression of C3G and the kinases. (B) Endogenous pY504 C3G 
colocalizes with c-Src. Cos-1 cells were transfected with the c-Src GFP fusion protein vector and cells stained for pY504-C3G 
expression (Cy3). c-Src expression was visualized as GFP fluorescence. Images shown are optical sections taken using the 
apotome. (C) Endogenous pY504-C3G localizes to the Golgi. Cos-1 cells were transfected with Hck along with VSVG-GFP and 
stained for pY504 C3G. Cells were left untreated (control) or treated with nocodazole (Noc) prior to fixation as described in 
Methods. Panels show optical section for pY504 by Cy3 and the VSVG-GFP by GFP fluorescence.
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Phosphorylation of endogenous C3G upon activation of endogenous tyrosine kinases Figure 5
Phosphorylation of endogenous C3G upon activation of endogenous tyrosine kinases. (A) Cells were either left 
untreated (UT) or treated with pervanadate (PV) and western blotting was performed using pY504 antibody. The same blot 
was reprobed with C3G to show the presence of endogenous C3G in these cells. (B) Cos-1 cells on coverslips were trans-
fected with either C3G or Y504F mutant of C3G and fixed without any treatment (cont.) or after pervanadate treatment (PV). 
Dual labeling was performed using the tag antibodies (stained with FITC) and pY504 antibody (stained with Cy3). Panels show 
optical sections obtained by confocal microscopy. (C) Cos-1 and HeLa cells grown on coverslips and transfected with VSVG-
GFP were fixed without any treatment (control) or after treatment with pervanadate and stained for pY504 expression. GFP 
fluorescence was used to visualize the staining pattern of VSVG-GFP protein. Optical sections taken using the apotome are 
shown. Areas of colocalization are seen from the yellow color generated in the merged images.
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phosphatases [35-37]. Pervanadate treatment results in
the dramatic augmentation of phosphorylation of a large
number of cellular proteins on tyrosine and therefore
mimics activation of signaling pathways by growth factors
[38]. While normal HeLa cells do not show any pY504
C3G, cells treated with pervanadate showed distinct pres-
ence of pY504 C3G in whole cell lysates as seen by west-
ern blotting (5A). The large number of other cellular
proteins phosphorylated on tyrosine (seen upon blotting
with antiphosphotyrosine antibodies), as a consequence
of pervanadate treatment, do not show reactivity with
pY504 antibody. In order to confirm that the signal
observed upon pervanadate treatment was specific to
phospho Y504-C3G, Cos-1 cells were transfected with
either C3G or Y504F mutant of C3G. They were left
untreated, or treated for 10 minutes with pervanadate and
indirect immunofluorescence performed to observe
expression of the wild type or mutant proteins as well as
that of phospho-C3G. C3G, and Y504FC3G expression
was monitored by staining for Flag and His tags respec-
tively. As observed in Fig. 5B only cells expressing C3G
showed intense staining for phosphoC3G while Y504F
expressing cells showed no enhanced signal above that of
the other non-expressing cells in the field. These results
reaffirmed the specificity of the phospho-C3G antibody in
detecting only Y504 phosphorylated C3G. Phosphor-
ylated endogenous C3G staining was seen weakly in the
non-expressing cells upon pervanadate treatment.
Indirect immunoflourescence was performed to deter-
mine the localization of endogenous pY504 C3G formed
by the activation of intracellular tyrosine kinases. Cos-1
and HeLa cells were stimulated by pervanadate and as
seen in Fig. 5C, pY504 C3G staining, which is evident only
in the treated cells, localized at the cell periphery and the
Golgi. Colocalization with VSVG confirmed its localiza-
tion to the Golgi complex. The staining at the cell periph-
ery appeared to match that of the subcortical actin
cytoskeleton. In order to confirm this, we dual stained the
cells treated with pervanadate for F-actin and found that
the pY504 C3G seen at the cell periphery colocalizes with
F-actin suggesting that pY504 C3G is targeted to the sub-
cortical actin cytoskeleton upon activation of endogenous
tyrosine kinases by pervanadate (Fig. 6A). It was also
observed that pY504 C3G staining at the cell periphery
was particularly prominent in confluent cells compared to
cells that were sparsely growing in isolation suggesting
that pY504 C3G is particularly enriched along cell-cell
junctions. Phospho C3G also shows partial colocalization
with filamentous actin known to be associated with the
Golgi complex [39].
We have observed that pervanadate treatment increased
tyrosine phosphorylation of endogenous C3G. Since
overexpression of Src as well as Hck results in phosphor-
ylation of C3G, it was of interest to determine whether
pervanadate induced tyrosine phosphorylation of C3G
was mediated by Src family kinases within the cell. Cells
were treated with PP2, a specific SFK inhibitor prior to PV
treatment [40]. As shown in Fig. 6B, pY504 C3G staining
of cells stimulated with pervanadate was considerably
reduced, but not totally abolished when they were pre-
treated with PP2 suggesting the possibility of other tyro-
sine kinase family members activated by pervanadate
contributing to C3G phosphorylation. To determine
whether the increase in pY504 C3G staining was
dependent on the presence of an intact cytoskeleton, we
observed its localization in cells treated with cytochalasin
D, a reagent that effectively disrupts the actin cytoskeletal
network. Under these conditions there is a collapse of cell
morphology and F-actin staining shows an irregular distri-
bution at the cell cortex. As observed in Fig. 6B, the stain-
ing for pY504 C3G in the subcortical cytoskeleton was
largely absent under conditions of moderate disruption of
actin organization. Under these conditions, pY504 C3G
staining at the Golgi complex, which shows a more dis-
persed morphology appeared not to be affected.
Discussion
C3G is involved in a variety of signaling pathways and
therefore its dynamic localization under normal and acti-
vated situations may be physiologically relevant. In this
study we demonstrate the limited subcellular distribution
of Y504 phosphorylated C3G, which is predominantly
targeted to the Golgi apparatus and the subcortical actin
cytoskeleton. This localization has been substantiated by
colocalization with a Golgi marker protein and F-actin
respectively.
Rap1, the substrate of C3G has been localized to the
Golgi, lysosomal vesicles and cortical actin cytoskeleton
[41]. But, of the at least eight known exchange factors for
Rap1, C3G is the only one that has been linked defini-
tively to the tyrosine kinase signaling pathway. Src family
members like Src and Hck have been shown to localize to
the plasma membrane and other intracellular membranes
with particular concentration in the Golgi [31,42]. When
endogenous C3G was phosphorylated by overexpressed
Hck or Src, the localization of pY504 C3G matched that of
the kinases suggesting that they may be part of the same
molecular complexes. This is also evident from the stain-
ing pattern of pY504 C3G when C3G is expressed along
with Hck, which is distinctly seen in the Golgi and plasma
membrane. Since exogenously expressed C3G is predom-
inantly cytosolic, it implies that, at any given time, only a
small fraction of it is phosphorylated at Y504 at the
plasma membrane and the Golgi.
We observed more exogenously expressed pY504 C3G in
the cytoplasmic compartment under conditions ofBMC Cell Biology 2004, 5:31 http://www.biomedcentral.com/1471-2121/5/31
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pY504C3G localizes to the subcortical actin cytoskeleton Figure 6
pY504C3G localizes to the subcortical actin cytoskeleton. (A) HeLa cells grown on coverslips were left untreated or 
treated with pervanadate and stained for pY504 expression using Cy3 secondaries. The coverslips were then stained with Ore-
gon-green phalloidin to detect F-actin. (B) C3G phosphorylation requires the activity of Src family kinases and the presence of 
an intact cytoskeleton. HeLa cells were pretreated with PP2 or cytochalasin D as described in methods prior to pervanadate 
treatment. Images show the localization of pY504 C3G labeled with Cy3 and F-actin stained with oregon green. Images shown 
are a single optical section visualized using the apotome.
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inhibition of tyrosine phosphatases suggesting that pY504
C3G may be targeted by cytosolic tyrosine phosphatases.
This regulation may help in restricting the activity of C3G
to specific compartments. We observe very little endog-
enous pY504 C3G in the cytosol when HeLa or Cos-1 cells
are treated with pervanadate, which not only inactivates
tyrosine phosphatases, but also activates tyrosine kinases.
It is possible that upon PV treatment endogenous C3G
present in the cells is phosphorylated at the sites of loca-
tion of the activated kinases. Pervanadate treatment has
been shown to increase phosphotyrosine staining at the
cell periphery indicating activation of kinases present in
this subcellular domain [43].
Recently c-Src and Jak2 have been implicated in the phos-
phorylation of C3G in response to growth hormone stim-
ulation of NIH 3T3 cells because dominant negative
mutants of these kinases inhibit C3G phosphorylation
[21]. It was suggested that this phosphorylation of endog-
enous C3G by c-Src occurs at Y504 because exogenously
expressed Y504F mutant of C3G was not phosphorylated.
Using a phosphospecific antibody we have directly shown
the phosphorylation of endogenous C3G at Y504 upon
overexpression of Hck [27] and c-Src (this report). c-Src is
present in Cos-1 and HeLa cells which lack Hck. c-Src
localizes to the cell membrane, focal adhesions and also
to the Golgi [42,44]. Since pervanadate is a good activator
of Src (36,37), it is possible that pY504 C3G seen in
pervanadate treated cells is because of C3G being a Src
substrate.
Adhesion dependent Src activation leads to Rap-1 activa-
tion mediated by Crk and C3G [14]. Fibroblasts lacking
C3G are essentially compromised in adhesion-mediated
responses [25,26]. The localization of endogenous pY504
C3G at the subcortical actin cytoskeleton therefore sug-
gests that this may be the site of action of C3G in mediat-
ing responses to cell adhesion. Modification of C3G by
phosphorylation at defined subcellular domains may be
important for restricted activation of C3G mediated sign-
aling functions in the cells. Close structural and
functional relationship is known to exist between the
structural elements at the cell periphery and the signal
transduction machinery. Several tyrosine kinases are
known to be located in adherence junctions and the kinet-
ics of phosphorylation and dephosphorylation appears to
be controlled by structural molecules at the junctions.
Our observation that disruption of actin cytoskeleton
results in a loss of pY504 C3G staining at the cell periph-
ery, but not at the Golgi complex reveals an important
role for cytoskeletal network in the regulation of C3G.
Conclusions
The activity of guanine nucleotide exchange factor C3G is
known to be regulated by tyrosine phosphorylation and
membrane targeting. Using phospho-specific antibodies,
we directly demonstrate that expression of Src family
kinases or pervanadate treatment of cells induces phos-
phorylation of C3G on Y504. Unlike C3G, which is
mostly cytosolic, pY504C3G locates to the Golgi and sub-
cortical actin cytoskeleton. Demonstration of the localiza-
tion of the active component of C3G to the Golgi and
subcortical cytoskeleton provides evidence for a possible
function for C3G at these cellular compartments.
Methods
Cell culture and treatment of cells
HeLa and Cos-1 cells were cultured in DMEM supple-
mented with 10% FCS. Transfections were performed on
cells grown as a monolayer in either 35 mm dishes or glass
coverslips using the cationic lipid DHDEAB as described
[45]. Briefly, 1 µl lipid diluted in 50 µl serum free DMEM
was mixed with 1 µg DNA in 50 µl serum free DMEM. The
mix was kept at room temperature for 30 min to allow
complex formation before adding to the cell monolayer.
Cells were fed with serum 5 hrs later and harvested 24–30
hrs after transfection.
Cells were subjected to pervanadate treatment by the
addition of a freshly prepared solution of pervanadate at
50 µM conc. for 10 min prior to harvesting. Pervanadate
stock solution (50 mM) was prepared by mixing equal
volumes of 100 mM solution of H2O2, with 100 mM
solution of sodium orthovanadate. It was added to the
cells within 5 mins of preparation. Golgi disruption was
performed by treating the cells with 5 µg/ml of nocada-
zole for 30 min prior to fixation. To disrupt actin cytoskel-
eton, cells were treated with 1 µg/ml cytochalasin D for 20
mins. PP2 was added to cells 2 hrs before pervanadate
treatment at a concentration of 10 µM to inhibit Src fam-
ily kinases.
Expression constructs
Full length human C3G cloned in pcDNA3-FLAG was
kindly provided by Dr S Tanaka. Y504F mutant of C3G in
which tyrosine 504 is mutated to phenylalanine cloned in
a His tagged expression vector was provided by Dr M Mat-
suda. The wild type rat p59 Hck cDNA was cloned in the
pCI plasmid (Promega) and has been described earlier
[27]. Expression plasmid for vesicular stomatitis virus
glycoprotein as a GFP fusion protein (VSVG-GFP) was a
kind gift from Jennifer Lippincott-Schwartz [32]. c-Src-
GFP expression vector expressing wild type c-Src fused to
GFP at C-terminal was from Dr D L Anders [46]. Wild type
human Hck cDNA cloned into pCDNA6 expression vector
was a kind gift of Dr Todd Miller [47].
Western blotting
Whole cell lysates were prepared by lysing cells directly in
Laemli's sample buffer and subjected to SDS-polyacryla-BMC Cell Biology 2004, 5:31 http://www.biomedcentral.com/1471-2121/5/31
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mide gel electrophoresis. After transfer onto nitrocellulose
membranes, they were processed for western blotting
using the required primary antibodies. Detection was
based on either color development using alkaline phos-
phatase conjugated secondary antibodies or on chemilu-
minescence using horse radish peroxidase conjugated
secondaries.
Indirect immunoflourescence and microscopy
Cells were processed for immunoflourescence staining as
described earlier [27]. The primary antibodies used were
rabbit polyclonal anti-C3G (Santa Cruz Biotechnology),
rabbit polyclonal anti pY504-C3G (SC-12926 R from
Santa Cruz) and anti-Hck (3E9 monoclonal) made in our
laboratory [48]. Dual labeling for Hck and C3G was per-
formed by incubating the cells serially with C3G anti-
body, anti rabbit Cy3, monoclonal anti-Hck, and anti-
mouse FITC. Cells were incubated with Oregon-green
phalloidin after staining for pY504 with Cy3 to visualize
F-actin. Cells transfected with vectors encoding GFP
fusion proteins (GFP-Src or VSVG) were observed directly
by fluorescent microscopy. Dual labeling for the C3G con-
structs and phospho-C3G was performed using the corre-
sponding monoclonal tag antibodies (detected by FITC)
and pY504 antibody (detected by Cy3). C3G was detected
using Flag tag antibody (from Sigma) and Y504FC3G by
His tag antibody (from Qiagen). Cells were examined
using an Olympus microscope equipped with a cool
SNAP color CCD camera. Images were captured using
Image Pro Plus software. Immunoflurescence staining and
colocalization was also observed using a Zeiss Axioplan 2
microscope fitted with an Apotome. The apotome (from
Carl Zeiss Microimaging) is a new 3D imaging system for
contrast enhancement in fluorescence microscopy. It uses
structured illumination to reject signals belonging to
regions of the sample that are outside the best focus posi-
tion of the microscope. Images were captured using the
Axiocam (Zeiss) CCD camera and processed using the
Axiovision 4 software. Colocalization was also deter-
mined by observing the staining patterns using the LSM
510 Meta confocal microscope from Carl Zeiss.
Abbreviations
GNEF – guanine nucleotide exchange factor
SFK – Src family kinase
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